Current Perspectives on Immunotherapy in the Peri-Operative Setting of Muscle-Infiltrating Bladder Cancer.

Zucali, Paolo Andrea; Cordua, Nadia; D'Antonio, Federica; Borea, Federica; Perrino, Matteo; De Vincenzo, Fabio; Santoro, Armando

Zucali, Paolo Andrea; Cordua, Nadia; D'Antonio, Federica; Borea, Federica; Perrino, Matteo; De Vincenzo, Fabio; Santoro, Armando.

Afiliación

Zucali PA; Department of Medical Oncology and Hematology, Humanitas Clinical and Research Center-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rozzano, Italy.
Cordua N; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
D'Antonio F; Department of Medical Oncology and Hematology, Humanitas Clinical and Research Center-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rozzano, Italy.
Borea F; Department of Medical Oncology and Hematology, Humanitas Clinical and Research Center-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rozzano, Italy.
Perrino M; Department of Medical Oncology and Hematology, Humanitas Clinical and Research Center-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rozzano, Italy.
De Vincenzo F; Department of Medical Oncology and Hematology, Humanitas Clinical and Research Center-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rozzano, Italy.
Santoro A; Department of Medical Oncology and Hematology, Humanitas Clinical and Research Center-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rozzano, Italy.

Front Oncol ; 10: 568279, 2020.

Article en En | MEDLINE | ID: mdl-33194654

Palabras clave

adjuvant; immunotherapy; muscle-infiltrating bladder cancer (MIBC); neoadjuvant; predictive biomarkers

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2020 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google